KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Minority Interest (2016 - 2018)

Neogenomics' Minority Interest history spans 4 years, with the latest figure at $35.5 million for Q1 2018.

  • For Q1 2018, Minority Interest rose 39.44% year-over-year to $35.5 million; the TTM value through Mar 2018 reached $35.5 million, up 39.44%, while the annual FY2017 figure was $32.6 million, 42.59% up from the prior year.
  • Minority Interest reached $35.5 million in Q1 2018 per NEO's latest filing, up from $32.6 million in the prior quarter.
  • In the past five years, Minority Interest ranged from a high of $45.3 million in Q3 2016 to a low of $22.9 million in Q4 2016.
  • Average Minority Interest over 4 years is $32.2 million, with a median of $31.4 million recorded in 2017.
  • The largest YoY upside for Minority Interest was 42.59% in 2017 against a maximum downside of 33.5% in 2017.
  • A 4-year view of Minority Interest shows it stood at $28.6 million in 2015, then fell by 20.03% to $22.9 million in 2016, then soared by 42.59% to $32.6 million in 2017, then grew by 8.76% to $35.5 million in 2018.
  • Per Business Quant, the three most recent readings for NEO's Minority Interest are $35.5 million (Q1 2018), $32.6 million (Q4 2017), and $30.1 million (Q3 2017).